SCHEDULE OF DEFERRED TAX ASSETS AND LIABILITIES (Details) - USD ($) |
Jun. 30, 2022 |
Jun. 30, 2021 |
---|---|---|
Deferred Tax Assets: | ||
Net operating loss carryforwards | $ 20,654,000 | $ 16,111,000 |
Research & development credit carryforward | 27,000 | 27,000 |
Stock compensation | 1,636,000 | 1,696,000 |
Interest expense Sec. 163 | 366,000 | |
Lease liability | 802,000 | 924,000 |
Other, net | 559,000 | 564,000 |
Gross deferred tax assets | 23,678,000 | 19,688,000 |
Valuation allowance for deferred tax assets | (22,951,000) | (18,839,000) |
Total deferred tax assets | 727,000 | 849,000 |
Deferred Tax Liabilities: | ||
Right of use asset | (727,000) | (849,000) |
Total deferred tax liabilities | (727,000) | (849,000) |
Net deferred tax liabilities |
X | ||||||||||
- Definition Interest expense. No definition available.
|
X | ||||||||||
- Definition Lease liability. No definition available.
|
X | ||||||||||
- Definition Right of use asset. No definition available.
|
X | ||||||||||
- Definition Amount of deferred tax liability attributable to taxable temporary differences. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- References No definition available.
|
X | ||||||||||
- Definition Amount after allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences and carryforwards. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible operating loss carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount, before allocation of valuation allowance, of deferred tax asset attributable to deductible temporary differences, classified as other. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible research tax credit carryforwards. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Amount before allocation of valuation allowances of deferred tax asset attributable to deductible temporary differences from share-based compensation. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
X | ||||||||||
- Definition Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Amount, after deferred tax asset, of deferred tax liability attributable to taxable differences without jurisdictional netting. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- References No definition available.
|